Abstract
A broad variety of bacterial strains, including 79 Pseudomonas aeruginosa, were studied in an in vitro evaluation of carbenicillin disk susceptibility testing. Regression analysis with both 50-μg and 100-μg carbenicillin disks was carried out. Organisms having minimal inhibitory concentration values of 100 to 200 μg/ml demonstrated zones of less than 11 mm with the 50-μg disk, resulting in very little opportunity for appropriate discrimination of results. The line of regression for the 50-μg disk intersected the ordinate at a point just above the minimal inhibitory concentration value considered to be the limit of intermediate susceptibility for Pseudomonas. These considerations, together with evidence of greater disk content variation in the 50-μg than in the 100-μg disks assayed, considerable manufacturer-to-manufacturer variability with the 50-μg disk, and the more appropriate performance of the 100-μg disk, lead us to conclude that the 100-μg disk better serves the clinical test requirements for this agent than does the 50-μg disk, which is currently the only disk available for laboratory testing.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Bodey G. P., Rodriguez V., Luce J. K. Carbenicillin therapy of gram-negative bacilli infections. Am J Med Sci. 1969 Jun;257(6):408–414. doi: 10.1097/00000441-196906000-00007. [DOI] [PubMed] [Google Scholar]
- Isenberg H. D., Siegel M. In vitro action of carbenicillin against bacteria isolated from clinical material. Appl Microbiol. 1969 Sep;18(3):387–392. doi: 10.1128/am.18.3.387-392.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lyons R. W., Thornton G. F., Andriole V. T. Carbenicillin: clinical and laboratory studies. J Infect Dis. 1970 Sep;122(Suppl):S104+–S104+. doi: 10.1093/infdis/122.supplement_1.s104. [DOI] [PubMed] [Google Scholar]
- Marks M. I., Eickhoff T. C. Carbenicillin: a clinical and laboratory evaluation. Ann Intern Med. 1970 Aug;73(2):179–187. doi: 10.7326/0003-4819-73-2-179. [DOI] [PubMed] [Google Scholar]
- Matsen J. M. Cephaloglycin in pediatric patients. Am J Dis Child. 1971 Jan;121(1):38–42. doi: 10.1001/archpedi.1971.02100120074009. [DOI] [PubMed] [Google Scholar]
- Solberg C. O., Kjellstrand K. M., Matsen J. M. Carbenicillin therapy of severe Pseudomonas aeruginosa infections. J Chronic Dis. 1971 Jun;24(1):19–28. doi: 10.1016/0021-9681(71)90055-5. [DOI] [PubMed] [Google Scholar]
- Traub W. H., Raymond E. A. Interpretation of diffusion susceptibility data obtained with 50-mu g carbenicillin discs against gram-negative organisms. Appl Microbiol. 1971 Nov;22(5):862–864. doi: 10.1128/am.22.5.862-864.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Traub W. H., Raymond E. A. Susceptibility of Pseudomonas aeruginosa to carbenicillin. Appl Microbiol. 1970 Oct;20(4):630–632. doi: 10.1128/am.20.4.630-632.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turck M., Silverblatt F., Clark H., Holmes K. The role of carbenicillin in treatment of infections of the urinary tract. J Infect Dis. 1970 Sep;122(Suppl):S29–S33. doi: 10.1093/infdis/122.supplement_1.s29. [DOI] [PubMed] [Google Scholar]
- Washington J. A., 2nd, Hall M. M., Fausch C. J., Brackin K. L. In vitro activity of carbenicillin against Pseudomonas using the disc diffusion method. Mayo Clin Proc. 1973 Oct;48(10):718–721. [PubMed] [Google Scholar]
- Wikins T. D., Holdeman L. V., Abramson I. J., Moore W. E. Standardized single-disc method for antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother. 1972 Jun;1(6):451–459. doi: 10.1128/aac.1.6.451. [DOI] [PMC free article] [PubMed] [Google Scholar]